Study Design

The Direct Answer If you already know a noninferiority trial compares a new treatment to an existing one instead of a placebo, here's the part that actually determines whether a "noninferior" result …

Continue Reading about A Noninferiority Trial: What Its Margin Means for Patients →

By ClinicalStudyConnect.com Research Desk An Interim Trial Analysis: Why Early Results Can Change An interim analysis is a planned look at a clinical trial's data before the study finishes enrolling …

Continue Reading about An Interim Trial Analysis: Why Early Results Can Change →

Short answer: check who was analyzed, and in which group When trial adherence is low, check who was analyzed and which group each person was counted in. An analysis by assigned group answers what …

Continue Reading about Trial Adherence Is Low: How to Read the Treatment Actually Received →

In an open-label trial, everyone involved — the person enrolled, the study team, and the doctors assessing outcomes — knows which treatment the participant is receiving. There is no placebo group …

Continue Reading about An Open-Label Trial: What Participants and Researchers Knew →

The Short Answer A clinical trial can be "blinded" in more than one place. Patients not knowing their treatment is only one form of blinding — and often the least important one for outcome accuracy. …

Continue Reading about Blinded Outcome Assessment: Why It Matters Even Without a Blindfolded Patient →

The Direct Answer A confidence interval is a range of numbers, not a single number. When a trial reports a result, it also reports a confidence interval — usually a 95% confidence interval — showing …

Continue Reading about Confidence Intervals in Trial Results: Range, Precision, and Uncertainty →